Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinically Significant Macular Edema Due to Diabetes Mellitus”

Showing 8 of 0 results

Early research (Phase 1)WithdrawnNCT00676559
What this trial is testing

Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study

Who this might be right for
Diabetic Macular Edema
Johns Hopkins University
Testing effectiveness (Phase 2)UnknownNCT00229918
What this trial is testing

PST/Laser v. Laser Alone for CSME

Who this might be right for
Diabetic Retinopathy
Edward Hines Jr. VA Hospital 60
Large-scale testing (Phase 3)Study completedNCT00133952
What this trial is testing

Effect of Ruboxistaurin on Clinically Significant Macular Edema

Who this might be right for
Diabetic Macular Edema
Chromaderm, Inc. 309
Testing effectiveness (Phase 2)Study completedNCT00815360
What this trial is testing

Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral Nonperfusion

Who this might be right for
Diabetic Macular Edema
Retina Associates of Florida, P.A. 22
Large-scale testing (Phase 3)Study completedNCT00780780
What this trial is testing

Efficacy Study of Triamcinolone Associated With Nepafenac for Treatment of Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Federal University of São Paulo 40
Not applicableStudy completedNCT01824862
What this trial is testing

Reduction of Foveal Sensitivity in Eyes With Diabetic Macular Edema

Who this might be right for
Diabetic RetinopathyClinically Significant Macular Edema
Hospital Juarez de Mexico 60
Testing effectiveness (Phase 2)Study completedNCT01319487
What this trial is testing

Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy

Who this might be right for
Diabetic Macular Edema
Fovea Pharmaceuticals SA 267
Not applicableEnded earlyNCT01141881
What this trial is testing

Evaluation of the Role of Intravitreal Tissue Plasminogen Activator in Treatment of Refractory Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Mashhad University of Medical Sciences

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation